PubMed

Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes.

Rother KI, Brown RJ, Morales MM, Wright E, Duan Z, Campbell C, Hardin DS, Popovic J, McEvoy RC, Harlan DM, Orlander PR, Brod SA.

Diabetes Care. 2009 Jul;32(7):1250-5. Erratum in: Diabetes Care. 2009 Sep;32(9):1751. PMID: 19564474 [PubMed - indexed for MEDLINE]Related articlesFree article

Bio-equivalence of IM and SQ H.P. Acthar Gel.

Brod SA, Morales MM.

Biomed Pharmacother. 2009 May;63(4):251-3. Epub 2008 Sep 17.PMID: 18848765 [PubMed - indexed for MEDLINE]Related articles

Ingested (oral) SIRS peptide 1-21 suppresses type 1 diabetes in NOD mice.

Brod SA, Hood Z.

J Interferon Cytokine Res. 2008 Jan;28(1):25-30.PMID: 18370869 [PubMed - indexed for MEDLINE]Related articles

Ingested (oral) alpha-MSH inhibits acute EAE.

Brod SA, Hood ZM.

J Neuroimmunol. 2008 Jan;193(1-2):106-12. Epub 2007 Nov 26.PMID: 18037504 [PubMed - indexed for MEDLINE]Related articles

Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th2-like cytokines.

Brod SA, Hood Z.

J Neuroimmunol. 2007 Feb;183(1-2):89-95. Epub 2006 Dec 29.PMID: 17196668 [PubMed - indexed for MEDLINE]Related articles

Ingested (oral) IFN-alpha represses TNF-alpha mRNA in relapsing-remitting multiple sclerosis.

Brod SA, Nguyen M, Hood Z, Shipley GL.

J Interferon Cytokine Res. 2006 Mar;26(3):150-5.PMID: 16542137 [PubMed - indexed for MEDLINE]Related articles

Ingested type I interferon: a potential treatment for autoimmunity.

Brod SA.

J Interferon Cytokine Res. 2002 Dec;22(12):1153-66. Review.PMID: 12581487 [PubMed - indexed for MEDLINE]Related articles

Ingested type I interferon: state of the art as treatment for autoimmunity.

Brod SA.

Exp Biol Med (Maywood). 2002 Dec;227(11):981-8. Review.PMID: 12486207 [PubMed - indexed for MEDLINE]Related articlesFree article

Ingested IFN-alpha preserves residual beta cell function in type 1 diabetes.

Brod SA, Atkinson M, Lavis VR, Brosnan PG, Hardin DS, Orlander PR, Nguyen M, Riley WJ.

J Interferon Cytokine Res. 2001 Dec;21(12):1021-30.PMID: 11798459 [PubMed - indexed for MEDLINE]Related articles

Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS.

Brod SA, Lindsey JW, Vriesendorp FS, Ahn C, Henninger E, Narayana PA, Wolinsky JS.

Neurology. 2001 Sep 11;57(5):845-52.PMID: 11552015 [PubMed - indexed for MEDLINE]Related articles

Unregulated inflammation shortens human functional longevity.

Brod SA.

Inflamm Res. 2000 Nov;49(11):561-70. Review.PMID: 11131295 [PubMed - indexed for MEDLINE]Related articles

Ingested interferon-alpha prevents allograft islet transplant rejection.

Brod SA, Katz S, Phan T, Stepkowski S.

Transplantation. 2000 May 27;69(10):2162-6.PMID: 10852617 [PubMed - indexed for MEDLINE]Related articles

Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion.

Brod SA, Khan M, Nelson LD, Decuir B, Malone M, Henninger E.

J Immunother. 2000 Mar-Apr;23(2):235-45.PMID: 10746550 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-alpha) does not improve experimental autoimmune encephalomyelitis.

Brod SA, Lindsey JW, Wolinsky JS.

Ann Neurol. 2000 Jan;47(1):127-31.PMID: 10632113 [PubMed - indexed for MEDLINE]Related articles

Autoimmunity is a type I interferon-deficiency syndrome corrected by ingested type I IFN via the GALT system.

Brod SA.

J Interferon Cytokine Res. 1999 Aug;19(8):841-52. Review.PMID: 10476927 [PubMed - indexed for MEDLINE]Related articles

Ingested interferon alpha induces Mx mRNA.

Brod SA, Nelson L, Jin R, Wolinsky JS.

Cytokine. 1999 Jul;11(7):492-9.PMID: 10419650 [PubMed - indexed for MEDLINE]Related articles

Ingested interferon alpha suppresses type I diabetes in non-obese diabetic mice.

Brod SA, Malone M, Darcan S, Papolla M, Nelson L.

Diabetologia. 1998 Oct;41(10):1227-32.PMID: 9794112 [PubMed - indexed for MEDLINE]Related articles

Hypothesis: multiple sclerosis is a type I interferon deficiency syndrome.

Brod SA.

Proc Soc Exp Biol Med. 1998 Sep;218(4):278-83. Review. No abstract available. PMID: 9714071 [PubMed - indexed for MEDLINE]Related articles

Gut response. Therapy with ingested immunomodulatory proteins.

Brod SA.

Arch Neurol. 1997 Oct;54(10):1300-2.PMID: 9341578 [PubMed - indexed for MEDLINE]Related articles

Increased in vitro induced CD4+ and CD8+ T cell IFN-gamma and CD4+ T cell IL-10 production in stable relapsing multiple sclerosis.

Brod SA, Nelson LD, Khan M, Wolinsky JS.

Int J Neurosci. 1997 Aug;90(3-4):187-202. Review.PMID: 9352427 [PubMed - indexed for MEDLINE]Related articles

IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months.

Brod SA, Nelson LD, Khan M, Wolinsky JS.

Int J Neurosci. 1997 Jun;90(1-2):135-44.PMID: 9285295 [PubMed - indexed for MEDLINE]Related articles

Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis.

Brod SA, Kerman RH, Nelson LD, Marshall GD Jr, Henninger EM, Khan M, Jin R, Wolinsky JS.

Mult Scler. 1997 Feb;3(1):1-7.PMID: 9160341 [PubMed - indexed for MEDLINE]Related articles

Multiple sclerosis: clinical presentation, diagnosis and treatment.

Brod SA, Lindsey JW, Wolinsky JS.

Am Fam Physician. 1996 Sep 15;54(4):1301-6, 1309-11. Review. Erratum in: Am Fam Physician 1997 Feb 1;55(2):448. PMID: 8816574 [PubMed - indexed for MEDLINE]Related articles

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.

Brod SA, Marshall GD Jr, Henninger EM, Sriram S, Khan M, Wolinsky JS.

Neurology. 1996 Jun;46(6):1633-8.PMID: 8649562 [PubMed - indexed for MEDLINE]Related articles

Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.

Brod SA, Khan M.

J Autoimmun. 1996 Feb;9(1):11-20.PMID: 8845048 [PubMed - indexed for MEDLINE]Related articles

Oral administration of type I interferon modulates the course of experimental allergic neuritis.

Vriesendorp FJ, Flynn RE, Khan M, Pappolla MA, Brod SA.

Autoimmunity. 1996;24(3):157-65.PMID: 9020408 [PubMed - indexed for MEDLINE]Related articles

Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis.

Brod SA, Khan M, Bright J, Sriram S, Marshall GD Jr, Henninger EM, Kerman RH, Wolinsky JS.

Ann Neurol. 1995 Apr;37(4):546-9.PMID: 7717692 [PubMed - indexed for MEDLINE]Related articles

Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis.

Brod SA, Khan M, Kerman RH, Pappolla M.

J Neuroimmunol. 1995 Apr;58(1):61-9.PMID: 7537281 [PubMed - indexed for MEDLINE]Related articles

Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.

Brod SA, Scott M, Burns DK, Phillips JT.

J Interferon Cytokine Res. 1995 Feb;15(2):115-22.PMID: 8590314 [PubMed - indexed for MEDLINE]Related articles

Treatment of autoimmune diseases by oral tolerance to autoantigens.

Weiner HL, Miller A, Khoury SJ, Zhang ZJ, al-Sabbagh A, Brod SA, Lider O, Higgins P, Sobel R, Matsui M, et al.

Adv Exp Med Biol. 1995;371B:1217-23. Review. No abstract available. PMID: 7502787 [PubMed - indexed for MEDLINE]Related articles

Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons.

Brod SA, Burns DK.

Neurology. 1994 Jun;44(6):1144-8.PMID: 8208413 [PubMed - indexed for MEDLINE]Related articles

Defective CD3 mediated proliferation and LPS responsiveness in multiple sclerosis.

Brod SA, Scott M.

Autoimmunity. 1994;17(2):143-8.PMID: 7520286 [PubMed - indexed for MEDLINE]Related articles

CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.

Freeman GJ, Lombard DB, Gimmi CD, Brod SA, Lee K, Laning JC, Hafler DA, Dorf ME, Gray GS, Reiser H, et al.

J Immunol. 1992 Dec 15;149(12):3795-801.PMID: 1281186 [PubMed - indexed for MEDLINE]Related articles

Antigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigens.

Weiner HL, Zhang ZJ, Khoury SJ, Miller A, al-Sabbagh A, Brod SA, Lider O, Higgins P, Sobel R, Nussenblatt RB, et al.

Ann N Y Acad Sci. 1991 Dec 30;636:227-32. Review. No abstract available. PMID: 1793212 [PubMed - indexed for MEDLINE]Related articles

Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease.

Brod SA, Benjamin D, Hafler DA.

J Immunol. 1991 Aug 1;147(3):810-5.PMID: 1907306 [PubMed - indexed for MEDLINE]Related articles

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.

Brod SA, al-Sabbagh A, Sobel RA, Hafler DA, Weiner HL.

Ann Neurol. 1991 Jun;29(6):615-22.PMID: 1716432 [PubMed - indexed for MEDLINE]Related articles

Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis.

Lee SJ, Wucherpfennig KW, Brod SA, Benjamin D, Weiner HL, Hafler DA.

Ann Neurol. 1991 Jan;29(1):33-40.PMID: 1847614 [PubMed - indexed for MEDLINE]Related articles

T-T cell interactions are mediated by adhesion molecules.

Brod SA, Purvee M, Benjamin D, Hafler DA.

Eur J Immunol. 1990 Oct;20(10):2259-68.PMID: 1700751 [PubMed - indexed for MEDLINE]Related articles

Frequency analysis of CD4+CD8+ T cells cloned with IL-4.

Brod SA, Purvee M, Benjamin D, Hafler DA.

Cell Immunol. 1990 Feb;125(2):426-36.PMID: 2105169 [PubMed - indexed for MEDLINE]Related articles

Lymphokine regulation of CD45R expression on human T cell clones.

Brod SA, Rudd CE, Purvee M, Hafler DA.

J Exp Med. 1989 Dec 1;170(6):2147-52.PMID: 2531196 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunoregulation in multiple sclerosis.

Hafler DA, Brod SA, Weiner HL.

Res Immunol. 1989 Feb;140(2):233-9; discussion 245-8. Review. No abstract available. PMID: 2525796 [PubMed - indexed for MEDLINE]Related articles

Lack of antibodies to Borrelia burgdorferi in patients with amyotrophic lateral sclerosis.

Mandell H, Steere AC, Reinhardt BN, Yoshinari N, Munsat TL, Brod SA, Clapshaw PA.

N Engl J Med. 1989 Jan 26;320(4):255-6. No abstract available. PMID: 2911315 [PubMed - indexed for MEDLINE]Related articles

Primary omphalomesenteric adrenocarcinoma with metastases to the brain.

Brod SA, Spencer SS, Kim JH.

Surg Neurol. 1988 Jul;30(1):68-70.PMID: 3394013 [PubMed - indexed for MEDLINE]Related articles

Predictors of success for drug discontinuation following neonatal seizures.

Brod SA, Ment LR, Ehrenkranz RA, Bridgers S.

Pediatr Neurol. 1988 Jan-Feb;4(1):13-7.PMID: 3233103 [PubMed - indexed for MEDLINE]Related articles